$37.86 -0.97 (%) ISIS Pharmaceuticals Inc - NASDAQ

Oct. 1, 2014 | 04:00 PM

Partner Headlines

  1. Brent Remains Below $97 On Weak Chinese Data

    Benzinga | Sep. 29, 2014 | 08:48AM EST
  2. Isis Pharmaceuticals Earns $4M from Achaogen For The Initiation Of A Phase 3 Study Of Plazomicin

    Benzinga | Sep. 17, 2014 | 07:27AM EST
  3. Making Money With Charles Payne: 08/29/14

    FoxBusiness | Sep. 3, 2014 | 10:33AM EST
  4. Tensions & Airlines Boost ETFs (ITA, PPA, BA, LMT)

    Benzinga | Aug. 27, 2014 | 15:46PM EST
  5. Companies With 'ISIS' Name Get Unwanted Attention

    FoxBusiness | Aug. 27, 2014 | 15:06PM EST
  6. Isis Pharmaceuticals Finally Breaks Out

    Benzinga | Aug. 27, 2014 | 12:30PM EST
  7. CNBC's Stock Pops & Drops From August 26

    Benzinga | Aug. 26, 2014 | 20:16PM EST
  8. Winners & Losers From Tuesday, August 26

    Benzinga | Aug. 26, 2014 | 16:02PM EST
  9. Fast Money Picks For August 26

    Benzinga | Aug. 25, 2014 | 20:03PM EST
  10. US Stock Futures Up Ahead Of Economic Data

    Benzinga | Aug. 15, 2014 | 07:50AM EST
  11. UPDATE: Laidlow & Co. Initiates Coverage on Isis Pharmaceuticals, Inc. at Buy, Announces $52.00 PT

    Benzinga | Aug. 12, 2014 | 11:34AM EST
  12. Isis Pharmaceuticals Initiates Phase 2 Study Of ISIS-APO(a) Rx In Patients With High Lp(a)

    Benzinga | Jul. 17, 2014 | 07:01AM EST
  13. Markets Edge Higher; Alcoa Profit Beats Street View

    Benzinga | Jul. 9, 2014 | 10:20AM EST
  14. US Stock Futures Edge Higher Ahead Of ADP Report

    Benzinga | Jul. 2, 2014 | 07:36AM EST
  15. Isis Pharmaceuticals Earns $1M From GSK For Advancing Hepatitis B Virus Program

    Benzinga | Jul. 2, 2014 | 07:00AM EST
  16. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 27, 2014 | 08:11AM EST
  17. Brent Steady As Iraqi Exports Look Unaffected

    Benzinga | Jun. 26, 2014 | 09:24AM EST
  18. Brent Retreats As Supply Interruption Worries Fade

    Benzinga | Jun. 24, 2014 | 09:34AM EST
  19. Brent Up To $115 As ISIS Moves Toward Baghdad

    Benzinga | Jun. 23, 2014 | 09:10AM EST
  20. Brent Climbs As Iraqi Oil Supplies Are Threatened

    Benzinga | Jun. 20, 2014 | 08:10AM EST
  21. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga | Jun. 19, 2014 | 10:27AM EST
  22. Morning Market Movers

    Benzinga | Jun. 19, 2014 | 09:36AM EST
  23. UPDATE: Isis Pharmaceuticals Earns $10M Milestone Payment from Biogen Idec

    Benzinga | Jun. 17, 2014 | 07:02AM EST
  24. US Stock Futures Decline Ahead Of Economic Data

    Benzinga | Jun. 16, 2014 | 07:32AM EST
  25. Isis Pharma Announces Final Phase 2 Data on ISIS-GCGR Rx Showing Significant Reduction in HbA1c for Type-2 Diabetes Patients

    Benzinga | Jun. 16, 2014 | 07:03AM EST
  26. Morning Market Movers

    Benzinga | Jun. 10, 2014 | 09:39AM EST
  27. US Stock Futures Down Ahead Of Wholesale Trade Data

    Benzinga | Jun. 10, 2014 | 07:35AM EST
  28. US Stock Futures Slightly Lower Ahead Of McDonald's Sales Report

    Benzinga | Jun. 9, 2014 | 07:27AM EST
  29. Mid-Day Market Update: Fossil Drops On Downbeat Outlook; SunOpta Shares Gain

    Benzinga | May. 14, 2014 | 12:28PM EST
  30. Mid-Morning Market Update: Markets Open Lower; Macy's Posts Rise In Profit

    Benzinga | May. 14, 2014 | 10:39AM EST
  31. Morning Market Movers

    Benzinga | May. 14, 2014 | 09:49AM EST
  32. Benzinga's Top #PreMarket Gainers

    Benzinga | May. 14, 2014 | 08:07AM EST
  33. US Stock Futures Edge Lower Ahead Of Producer Price Index

    Benzinga | May. 14, 2014 | 07:14AM EST
  34. UPDATE: Piper Jaffray Upgrades ISIS Pharmaceuticals Following Mixed 1Q Results

    Benzinga | May. 7, 2014 | 08:29AM EST
  35. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | May. 1, 2014 | 07:34AM EST
  36. Mid-Day Market Update: Twitter Drops On Earnings; Pepco Shares Gain

    Benzinga | Apr. 30, 2014 | 13:18PM EST
  37. Isis Pharmaceuticals Shares Dropping Futher After Company released Updated Phase 3 Results Tuesday Afternoon; Shares Down Over 12.5 Percent

    Benzinga | Apr. 30, 2014 | 12:07PM EST
  38. UPDATE: Isis Pharma Offers Updated Results from ISIS-SMN Rx Clinical Studies

    Benzinga | Apr. 29, 2014 | 13:47PM EST
  39. Isis Pharmaceuticals to Present ISIS-SMN Rx Data at 2014 AAN Annual Meeting

    Benzinga | Apr. 22, 2014 | 07:04AM EST
  40. Isis Reports Final Phase 2 Data on ISIS-APOCIII Rx

    Benzinga | Mar. 31, 2014 | 09:31AM EST
  41. EARLIER: Isis Announces Antisense Targeting of HBV Produces Dose-Dependent Reductions in Hepatitis B Virus in an Animal Model of HBV

    Benzinga | Mar. 24, 2014 | 07:17AM EST
  42. BioMed Realty Trust Leases Space To Life Science Firms

    IBD | Mar. 19, 2014 | 17:05PM EST
  43. US Stock Futures Edge Higher; All Eyes On Fed

    Benzinga | Mar. 19, 2014 | 07:26AM EST
  44. US Stock Futures Tumble Ahead Of Economic Data

    Benzinga | Mar. 3, 2014 | 07:20AM EST
  45. Earnings Scheduled For February 28, 2014

    Benzinga | Feb. 28, 2014 | 04:58AM EST
  46. Mid-Afternoon Market Update: Groupon Shares Continue to Show Weakness Following Earnings as Isis Pharmaceuticals Rallies

    Benzinga | Feb. 21, 2014 | 15:43PM EST
  47. Mid-Day Market Update: Acacia Research Shares Decline On Downbeat Results; Emeritus Spikes Higher

    Benzinga | Feb. 21, 2014 | 12:31PM EST
  48. US Stock Futures Rise Ahead Of Existing-Home Sales Data

    Benzinga | Feb. 21, 2014 | 07:28AM EST
  49. Isis Pharmaceuticals Earns $2M Milestone Payment from GSK for Advancement of ISIS-TTR Rx

    Benzinga | Dec. 2, 2013 | 07:02AM EST
  50. UPDATE: Piper Jaffray Assumes Coverage on ISIS Pharmaceuticals as Company's Antisense Platform Continues to Advance

    Benzinga | Nov. 27, 2013 | 08:34AM EST
Trading Center